LSE - Delayed Quote GBp

Avacta Group Plc (AVCT.L)

45.00 -0.30 (-0.66%)
At close: April 25 at 5:06 PM GMT+1
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for AVCT.L

Recent News: AVCT.L

View More
Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update

Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update
GlobeNewswire 20 days ago
Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024

Updated Results from Single-Agent Phase 1 Clinical Trial of Peptide Drug Conjugate, AVA6000 to be Presented in a Poster at the American Association of Cancer Research (AACR) Annual Meeting on April 9, 2024
GlobeNewswire last month
Avacta Group Plc (LON:AVCT) is a favorite amongst institutional investors who own 53%

Avacta Group Plc (LON:AVCT) is a favorite amongst institutional investors who own 53%
Simply Wall St. 2 months ago
Appointment of Chief Business Officer

Appointment of Chief Business Officer
GlobeNewswire 4 months ago
ALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study Data

ALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study Data
GlobeNewswire 4 months ago
Levicept Appoints Eliot Forster as CEO

Levicept Appoints Eliot Forster as CEO
GlobeNewswire 4 months ago
Avacta Group's (LON:AVCT) growing losses don't faze investors as the stock soars 11% this past week

Avacta Group's (LON:AVCT) growing losses don't faze investors as the stock soars 11% this past week
Simply Wall St. 5 months ago
Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board

Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board
PR Newswire 5 months ago
Avacta to present promising new data from Affimer® and pre|CISIONTM platform assets at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Avacta to present promising new data from Affimer® and pre|CISIONTM platform assets at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
GlobeNewswire 6 months ago
US stocks mixed as FTSE and European stocks fall ahead of US GDP update

US stocks mixed as FTSE and European stocks fall ahead of US GDP update
Yahoo Finance UK 6 months ago
Avacta Group Plc (LON:AVCT) is largely controlled by institutional shareholders who own 53% of the company

Avacta Group Plc (LON:AVCT) is largely controlled by institutional shareholders who own 53% of the company
Simply Wall St. 7 months ago
Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study

Avacta Announces Successful Completion of Fifth Dose Escalation in AVA6000 Phase 1 Clinical Study
Business Wire 9 months ago
View More

Related Tickers

BSFA.L BSF Enterprise Plc
4.7500
-5.00%
 
DEST.L Destiny Pharma plc
16.75
-22.09%
 
SNG.L Synairgen plc
6.59
+2.97%
 
HEMO.L Hemogenyx Pharmaceuticals Plc
1.5850
-1.43%
 
REDX.L Redx Pharma Plc
10.00
+8.11%
 
FUM.L Futura Medical plc
35.40
-1.12%
 
POLB.L Poolbeg Pharma PLC
11.60
+0.87%
 
FARN.L Faron Pharmaceuticals Oy
127.50
0.00%
 
SBTX.L SkinBioTherapeutics plc
9.25
0.00%
 
APTA.L Aptamer Group plc
0.8500
-2.86%